Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Mobile ECG Devices Market, by Modality
1.4.2 Europe Mobile ECG Devices Market, by End-use
1.4.3 Europe Mobile ECG Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Apr – 2023, Oct) Leading Players
4.4 Porter’s Five Force Analysis
Chapter 5. Europe Mobile ECG Devices Market, by Modality
5.1 Europe Handheld Market, by Country
5.2 Europe Band Market, by Country
5.3 Europe Pen Market, by Country
5.4 Europe Others Market, by Country
Chapter 6. Europe Mobile ECG Devices Market, by End-use
6.1 Europe Hospitals & Diagnostic Centers Market, by Country
6.2 Europe Ambulatory Care Market, by Country
6.3 Europe Homecare Market, by Country
Chapter 7. Europe Mobile ECG Devices Market, by Country
7.1 Germany Mobile ECG Devices Market
7.1.1 Germany Mobile ECG Devices Market, by Modality
7.1.2 Germany Mobile ECG Devices Market, by End-use
7.2 UK Mobile ECG Devices Market
7.2.1 UK Mobile ECG Devices Market, by Modality
7.2.2 UK Mobile ECG Devices Market, by End-use
7.3 France Mobile ECG Devices Market
7.3.1 France Mobile ECG Devices Market, by Modality
7.3.2 France Mobile ECG Devices Market, by End-use
7.4 Russia Mobile ECG Devices Market
7.4.1 Russia Mobile ECG Devices Market, by Modality
7.4.2 Russia Mobile ECG Devices Market, by End-use
7.5 Spain Mobile ECG Devices Market
7.5.1 Spain Mobile ECG Devices Market, by Modality
7.5.2 Spain Mobile ECG Devices Market, by End-use
7.6 Italy Mobile ECG Devices Market
7.6.1 Italy Mobile ECG Devices Market, by Modality
7.6.2 Italy Mobile ECG Devices Market, by End-use
7.7 Rest of Europe Mobile ECG Devices Market
7.7.1 Rest of Europe Mobile ECG Devices Market, by Modality
7.7.2 Rest of Europe Mobile ECG Devices Market, by End-use
Chapter 8. Company Profiles
8.1 New York Plastic Surgical Group, PC (Long Island Plastic Surgical Group, PC)
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Nihon Kohden Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Product Category and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 GE HealthCare Technologies, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.6 SWOT Analysis
8.4 Medtronic PLC
8.4.1 Company overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Trials and Approvals:
8.4.5.2 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 iRhythm Technologies, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.5.4 Recent strategies and developments:
8.5.4.1 Trials and Approvals:
8.5.5 SWOT Analysis
8.6 Koninklijke Philips N.V.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.6.5.2 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Omron Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Product Launches and Product Expansions:
8.7.5.2 Partnerships, Collaborations, and Agreements:
8.7.6 SWOT Analysis
8.8 AliveCor, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.8.2.3 Trials and Approvals:
8.8.3 SWOT Analysis
8.9 EMAY
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. Nureca Limited (Dr Trust)
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Recent strategies and developments:
8.10.3.1 Product Launches and Product Expansions:
8.10.4 SWOT Analysis
Unique Offerings 